Coherus Oncology Inc (CHRS)

Cash & Equivalents

$82.92M

Quarterly · Period ending: · USD

CHRS logo

CHRS Cash & Equivalents

Latest reported$82.92M
CHRS Quarterly Cash & Equivalents (-$14.55M → $82.92M)
High-resolution chart · PNG

CHRS cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
82,923,000
115,238,000
88,879,000
103,352,000
216,893,000
82,411,000
125,987,000
97,690,000
159,240,000
259,775,000
102,891,000
80,711,000
73,360,000
16,585,000
63,547,000
286,805,000
275,484,000
325,680,000
417,195,000
360,540,000
329,738,000
259,489,000
541,158,000
292,465,000
224,617,000
193,252,000
177,668,000
165,116,000
105,927,000
81,515,000
72,356,000
101,202,000
130,005,000
82,021,000
126,911,000
135,557,000
73,352,000
124,924,000
124,947,000
159,677,000
220,916,000
179,558,000
158,226,000
153,691,000
206,088,000
115,136,000
150,392,000
100,875,000
108,869,000
56,317,000
39,554,000
-14,548,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.